This paper is in the following e-collection/theme issue:

Theme Issue 2019: The Eastern Mediterranean Public Health Network (EMPHNET) (18)

Published on in Vol 6, No 1 (2020): Jan-Mar

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/14439, first published .
Trend of Cutaneous Leishmaniasis in Jordan From 2010 to 2016: Retrospective Study

Trend of Cutaneous Leishmaniasis in Jordan From 2010 to 2016: Retrospective Study

Trend of Cutaneous Leishmaniasis in Jordan From 2010 to 2016: Retrospective Study

Authors of this article:

Mohammad Alhawarat1 Author Orcid Image ;   Yousef Khader2 Author Orcid Image ;   Bassam Shadfan3 Author Orcid Image ;   Nasser Kaplan2 Author Orcid Image ;   Ibrahim Iblan1 Author Orcid Image
Article Authors Cited by (9) Tweetations (3) Metrics

Journals

  1. Hatami H, Ramezankhani A, Hasannezhad E, Souri A. Epidemiological Study of Cutaneous Leishmaniasis in the Population Covered by Shahid Beheshti University of Medical Sciences in Iran from 2011 to 2021. International Journal of Infection 2022;9(4) View
  2. Shtaiwi A. Thiadiazine-thiones as inhibitors of leishmania pteridine reductase (PTR1) target: investigations and in silico approach. Journal of Biomolecular Structure and Dynamics 2024;42(16):8588 View
  3. Msellemu D, Tanner M, Yadav R, Moore S. Occupational exposure to malaria, leishmaniasis and arbovirus vectors in endemic regions: A systematic review. Current Research in Parasitology & Vector-Borne Diseases 2024;6:100185 View
  4. Abbara A, González-Sanz M, AlKharrat A, Khalife M, Elferruh Y, Almhawish N, Abbara S, Marroush S, Shortall C, Ahmed S, Alhazmi A, Alvarez-Martinez M, Asaduzzaman M, Al Balushi A, Barboza A, Brekke H, Di Carlo P, Cascio A, Chiodini P, Colpani A, Díaz-Menéndez M, Elkheir N, Farkas F, Garg P, Grüner B, Guimarães A, Holmberg V, Ioannou P, Jordão S, Kim J, Lakatos B, Leblebicioglu H, Llenas-García J, Losada-Galván I, Martinez G, Monk E, Nedu E, Nwofe J, O'Regan R, Paggi R, Pinho J, Pontali E, Priyadarshi M, Rath B, Rathish B, Rezzonico L, Rizk N, Ronnberg C, Morante-Ruiz M, Salvati A, Scarso S, Sempere-Alcocer M, Sepulcri C, Costescu Strachinaru D, Tamarozzi F, Tavares R, Ursini T, Verweij J, Wejse C, Rodriguez-Morales A. Leishmaniasis in Syria – A call for action of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Groups for Infections in Travellers and Migrants (ESGITM) and for Clinical Parasitology (ESGCP). Travel Medicine and Infectious Disease 2025;66:102849 View
  5. Kim J, Zieneldien T, Ma S, Cohen B. Cutaneous Leishmaniasis in the Context of Global Travel, Migration, Refugee Populations, and Humanitarian Crises. Clinics and Practice 2025;15(4):77 View
  6. Boukert R, Foughali A, Saidj D, Kalthoum S, Achour S, Sahraoui N. Epidemiology of cutaneous leishmaniasis in Algeria, 2010–2019. Journal of Parasitic Diseases 2025 View
  7. Elafef E, Maatoug T, Evangelidou S, Marti-Soler H, Adam A, Arisha A, Hilali M, Hargreaves S, Bani I, Seedat F, Requena-Méndez A. The burden, clinical outcomes and risk factors related to neglected tropical diseases and malaria in migrant populations in the Middle East and North Africa: a systematic review and meta-analyses. BMJ Global Health 2025;10(11):e019713 View
  8. Hananeh W, Al Rukibat R, Hammad H, Mukbel R. Review of animal leishmaniosis in Jordan: An alarming discovery with implications for public health and animal welfare. Veterinary Parasitology: Regional Studies and Reports 2025;66:101382 View
  9. Carew J, Simpson R, Pillay T, Desai A, Toalster R, Parkes P, Abbara A, Rotureau B. Vector-borne diseases and the Syrian conflict: A systematic review of literature from Syria and neighbouring, refugee-hosting countries. PLOS Neglected Tropical Diseases 2025;19(11):e0013721 View